Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

147.11 +5.78 (+4.09%)
Official Closing Price Updated: 4:15 PM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
What If the Future Looked Back at Us? A New Sci-Fi Project Explores Gender, Power, and Perspective
NEW YORK, N.Y., Dec. 19, 2025 (SEND2PRESS NEWSWIRE) -- What if men had to prove they were marriage material? What if men were judged by their biceps and facial symmetry? What if men needed to smile... 
Via Send2Press
News headline image
Latin America’s Next-Generation Sequencing (NGS) Market Set to Reach $597.2 Million by 2034, Driven by Cancer Genomics and Personalized Medicine
Via AB Newswire
News headline image
iRhythm Technologies Announces Board Member Retirements and New Director Appointments
From iRhythm
Via GlobeNewswire
CD Genomics Enhances Whole Genome SNP Genotyping Services to Propel Genomic Discoveries
Via Press Release Distribution Service
News headline image
Leading the Way: Swoop Named Provider of Choice for Employee Shuttling by Fortune 500 & Renowned Technology Companies
LOS ANGELES - March 20, 2024 - PRLog -- Swoop Inc. the leading group transportation service provider, is proud to announce its recent success in providing best-in-class employee shuttling services to... 
Via PRLog
Illumina Inc. (NASDAQ: ILMN) Highlighted for Surprising Price Action
Via Investor Brand Network
News headline image
“Mag 7 Undercard Movers: IBO, SNYR, CTOR, PNPN.V, LAB – Breakthroughs in Military Defense, Tech, Medical & Healthcare Fuel Market Buzz”
Via AB Newswire
Topics Artificial Intelligence
News headline image
Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:ILMN),(NASDAQ:TEM),(NYSE:MDT),(NASDAQ:MDAI) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations
From FN Media Group LLC
Via GlobeNewswire
News headline image
GenoFAB Launches Hybrid Plasmid Sequencing Service To Set a New Standard for Reproducibility in Biotechnology
Via Get News
CD Genomics Unveils Advanced Mitochondrial DNA Sequencing to Deepen Insights into Genetic Research
Via Press Release Distribution Service
News headline image
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
Agreement will expand worldwide access and better position Myriad’s GIS as a potential companion diagnostic across multiple potential tumor types 
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Strategic Buy Lights Up This Biotech Stock: Time to Invest?
Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. 
Via MarketBeat
News headline image
Palantir Was Left Out of the S&P 500; It Still Looks Like a Buy
Palantir stock dropped about 2% after news that it will not be added to the S&P 500, but despite the short-term setback, PLTR is still a solid long-term buy 
Via MarketBeat
Topics Stocks
News headline image
ILLUMINA ALERT: Bragar Eagel & Squire, P.C. is Investigating Illumina, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Fall in Love with ‘Galaxy 360: A Woman’s Playground’ this Valentine’s Day
Via Get News
News headline image
MarketBeat ‘Stock of the Week’: Intuitive Surgical hits new highs
With recent obesity drug fears proving to be overblown and equipment placements growing, expect ISRG to reward growth investors with plenty more record highs. 
Via MarketBeat
Topics Earnings
News headline image
ILMN DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Illumina, Inc. (ILMN)
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
ILMN DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
ILLUMINA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ILMN FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action – ILMN
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
ILLUMINA SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acelyrin, Illumina, and Roblox and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN
WHY: NEW YORK, NY - (NewMediaWire) - December 29, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. (NASDAQ: ILMN) between May 1, 2023 and... 
Via NewMediaWire
Topics Lawsuit
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acelyrin, Illumina, and Roblox and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action – ILMN
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
ILLUMINA SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
ROSEN, A LONGSTANDING LAW FIRM, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ILMN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.